In the last week, the Biotech industry is up 2.8%, with Regeneron Pharmaceuticals leading the way, up 8.6%. This takes the industry's 12 month performance to a gain of 12%. As for the next few years, earnings are expected to grow by 30% per annum.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 14 Aug 2024 | US$861.0b | US$113.0b | -US$36,639,604,267.04 | 22.7x | -23.5x | 7.6x |
Fri, 12 Jul 2024 | US$1.2t | US$164.5b | -US$28,077,075,512.80 | 29.6x | -41.5x | 7.1x |
Sun, 09 Jun 2024 | US$1.2t | US$164.5b | -US$26,798,622,131.21 | 28.1x | -43.1x | 7x |
Tue, 07 May 2024 | US$1.1t | US$162.6b | -US$27,558,558,120.24 | 27.4x | -40.8x | 6.9x |
Thu, 04 Apr 2024 | US$1.1t | US$164.3b | -US$23,560,093,353.12 | 23.5x | -48.7x | 7x |
Sat, 02 Mar 2024 | US$1.2t | US$167.9b | -US$21,266,980,809.75 | 15.9x | -55.4x | 7x |
Mon, 29 Jan 2024 | US$1.4t | US$204.7b | -US$22,652,938,045.00 | 18.3x | -63.1x | 7x |
Wed, 27 Dec 2023 | US$1.4t | US$204.9b | -US$22,191,084,128.00 | 19.6x | -61.8x | 6.7x |
Fri, 24 Nov 2023 | US$1.2t | US$204.7b | -US$22,047,730,821.00 | 18x | -55.3x | 6x |
Sun, 22 Oct 2023 | US$1.2t | US$207.4b | -US$13,088,260,702.00 | 16.6x | -93.6x | 5.9x |
Tue, 19 Sep 2023 | US$1.3t | US$207.5b | -US$12,859,693,014.00 | 17.2x | -99.5x | 6.2x |
Thu, 17 Aug 2023 | US$1.3t | US$207.7b | -US$12,321,742,893.00 | 17.7x | -103.2x | 6.1x |
Sat, 15 Jul 2023 | US$1.1t | US$186.7b | -US$15,944,193,566.00 | 13.3x | -71.2x | 6.1x |
Mon, 12 Jun 2023 | US$1.1t | US$186.0b | -US$15,970,598,297.00 | 11.7x | -71.6x | 6.2x |
Wed, 10 May 2023 | US$1.2t | US$192.6b | -US$11,459,990,654.00 | 14.5x | -101.7x | 6x |
Fri, 07 Apr 2023 | US$1.2t | US$216.9b | -US$5,766,366,754.00 | 14.5x | -201.7x | 5.4x |
Sun, 05 Mar 2023 | US$1.2t | US$199.0b | -US$4,964,241,359.00 | 16.5x | -232.2x | 5.8x |
Tue, 31 Jan 2023 | US$1.2t | US$203.7b | US$1.7b | 14.6x | 660.8x | 5.7x |
Thu, 29 Dec 2022 | US$1.1t | US$203.3b | US$1.6b | 14.2x | 689x | 5.5x |
Sat, 26 Nov 2022 | US$1.1t | US$202.3b | US$1.3b | 14.6x | 845.6x | 5.6x |
Mon, 24 Oct 2022 | US$1.1t | US$206.2b | US$5.3b | 15.8x | 200.9x | 5.2x |
Wed, 21 Sep 2022 | US$1.1t | US$206.6b | US$5.8b | 14.4x | 180x | 5.1x |
Fri, 19 Aug 2022 | US$1.1t | US$206.6b | US$7.3b | 16.2x | 148.6x | 5.3x |
Sun, 17 Jul 2022 | US$1.1t | US$211.3b | US$10.6b | 17.2x | 102.8x | 5.2x |
Tue, 14 Jun 2022 | US$917.5b | US$212.1b | US$10.9b | 14.2x | 84x | 4.3x |
Thu, 12 May 2022 | US$938.1b | US$210.6b | US$12.5b | 12.8x | 75.3x | 4.5x |
Sat, 09 Apr 2022 | US$1.3t | US$226.8b | US$14.3b | 18.8x | 92x | 5.8x |
Mon, 07 Mar 2022 | US$1.2t | US$221.9b | US$10.6b | 18.9x | 114x | 5.4x |
Wed, 02 Feb 2022 | US$1.3t | US$212.3b | US$2.5b | 23.3x | 505.3x | 6x |
Fri, 31 Dec 2021 | US$1.4t | US$212.0b | US$2.8b | 26x | 517.9x | 6.8x |
Sun, 28 Nov 2021 | US$1.5t | US$211.9b | US$3.2b | 25x | 461x | 6.9x |
Tue, 26 Oct 2021 | US$1.5t | US$196.3b | -US$2,796,498,972.00 | 24x | -535.8x | 7.6x |
Thu, 23 Sep 2021 | US$1.6t | US$196.3b | -US$2,199,783,766.00 | 25.1x | -711.8x | 8x |
Sat, 21 Aug 2021 | US$1.5t | US$197.0b | -US$1,662,914,785.58 | 22.1x | -923.9x | 7.8x |
-923.9x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 3.57% | |
Healthcare | 2.87% | |
Biotech | 2.78% | |
Biotech | 2.78% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals | US$1.16k | 8.6% +US$9.9b | 43.7% | PE28.9x | |
ABBV AbbVie | US$191.23 | 3.0% +US$9.8b | 25.7% | PE63.8x | |
NTRA Natera | US$119.02 | 17.9% +US$2.3b | 117.1% | PS10.8x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
BGNE BeiGene | US$187.20 | 9.3% +US$1.7b | -7.7% | PS6.4x |